Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

Por Harandi, Amir, Zaidi, Aisha S., Stocker, Abigail M., Laber, Damian A.
Publicado em 2009

Discovery and Development of the G-rich Oligonucleotide AS1411 as a Novel Treatment for Cancer

Por Bates, Paula J., Laber, Damian A., Miller, Donald M., Thomas, Shelia D., Trent, John O.
Publicado em 2009

Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy

Por Sandoval-Sus, Jose D., Mogollon-Duffo, Francis, Patel, Ankita, Visweshwar, Nathan, Laber, Damian A., Kim, Richard, Jagal, Michael V.
Publicado no J Immunother Cancer (2017)

A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma

Por Rosenberg, Jonathan E., Bambury, Richard, Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Figlin, Robert A., Smith, Gregory W., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Publicado no Invest New Drugs (2013)